These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 21355053)

  • 21. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians.
    Pavkov ME; Bennett PH; Knowler WC; Krakoff J; Sievers ML; Nelson RG
    JAMA; 2006 Jul; 296(4):421-6. PubMed ID: 16868300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology of diabetic kidney disease.
    Reutens AT
    Med Clin North Am; 2013 Jan; 97(1):1-18. PubMed ID: 23290726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
    Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
    Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cumulative risk, age at onset, and sex-specific differences for developing end-stage renal disease in young patients with type 1 diabetes: a nationwide population-based cohort study.
    Möllsten A; Svensson M; Waernbaum I; Berhan Y; Schön S; Nyström L; Arnqvist HJ; Dahlquist G; ; ;
    Diabetes; 2010 Jul; 59(7):1803-8. PubMed ID: 20424230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urine matrix metalloproteinase-7 and risk of kidney disease progression and mortality in type 2 diabetes.
    Afkarian M; Zelnick LR; Ruzinski J; Kestenbaum B; Himmelfarb J; de Boer IH; Mehrotra R
    J Diabetes Complications; 2015; 29(8):1024-31. PubMed ID: 26412030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time trends in the epidemiology of renal transplant patients with type 1 diabetes mellitus over the last four decades.
    Cao C; Hellermann JP; Weber M; Ambühl PM
    Nephrol Dial Transplant; 2006 Mar; 21(3):770-5. PubMed ID: 16401627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes.
    Niewczas MA; Gohda T; Skupien J; Smiles AM; Walker WH; Rosetti F; Cullere X; Eckfeldt JH; Doria A; Mayadas TN; Warram JH; Krolewski AS
    J Am Soc Nephrol; 2012 Mar; 23(3):507-15. PubMed ID: 22266663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of end-stage renal disease in patients with type 1 diabetes.
    Finne P; Reunanen A; Stenman S; Groop PH; Grönhagen-Riska C
    JAMA; 2005 Oct; 294(14):1782-7. PubMed ID: 16219881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ethnic differences in the natural progression of nephropathy among diabetes patients in New Zealand: hospital admission rate for renal complications, and incidence of end-stage renal disease and renal death.
    Joshy G; Dunn P; Fisher M; Lawrenson R
    Diabetologia; 2009 Aug; 52(8):1474-8. PubMed ID: 19436991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes.
    Thomas MC; Moran J; Forsblom C; Harjutsalo V; Thorn L; Ahola A; Wadén J; Tolonen N; Saraheimo M; Gordin D; Groop PH;
    Diabetes Care; 2011 Apr; 34(4):861-6. PubMed ID: 21307382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Added value of soluble tumor necrosis factor-α receptor 1 as a biomarker of ESRD risk in patients with type 1 diabetes.
    Forsblom C; Moran J; Harjutsalo V; Loughman T; Wadén J; Tolonen N; Thorn L; Saraheimo M; Gordin D; Groop PH; Thomas MC;
    Diabetes Care; 2014 Aug; 37(8):2334-42. PubMed ID: 24879837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort.
    de Boer IH; Rue TC; Cleary PA; Lachin JM; Molitch ME; Steffes MW; Sun W; Zinman B; Brunzell JD; ; White NH; Danis RP; Davis MD; Hainsworth D; Hubbard LD; Nathan DM
    Arch Intern Med; 2011 Mar; 171(5):412-20. PubMed ID: 21403038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic Evidence for a Causal Role of Obesity in Diabetic Kidney Disease.
    Todd JN; Dahlström EH; Salem RM; Sandholm N; Forsblom C; ; McKnight AJ; Maxwell AP; Brennan E; Sadlier D; Godson C; Groop PH; Hirschhorn JN; Florez JC
    Diabetes; 2015 Dec; 64(12):4238-46. PubMed ID: 26307587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early-Onset Type 2 Diabetes as a Risk Factor for End-Stage Renal Disease in Patients With Diabetic Kidney Disease.
    Zheng L; Chen X; Luo T; Ran X; Hu J; Cheng Q; Yang S; Wu J; Li Q; Wang Z
    Prev Chronic Dis; 2020 Jul; 17():E50. PubMed ID: 32614772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Depression Is Associated With Progression of Diabetic Nephropathy in Type 1 Diabetes.
    Ahola AJ; Harjutsalo V; Forsblom C; Pouwer F; Groop PH;
    Diabetes Care; 2021 Jan; 44(1):174-180. PubMed ID: 33177173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma Copeptin, Kidney Outcomes, Ischemic Heart Disease, and All-Cause Mortality in People With Long-standing Type 1 Diabetes.
    Velho G; El Boustany R; Lefèvre G; Mohammedi K; Fumeron F; Potier L; Bankir L; Bouby N; Hadjadj S; Marre M; Roussel R
    Diabetes Care; 2016 Dec; 39(12):2288-2295. PubMed ID: 27729425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low incidence of end-stage renal disease and chronic renal failure in type 2 diabetes: a 10-year prospective study.
    Bruno G; Biggeri A; Merletti F; Bargero G; Ferrero S; Pagano G; Perin PC
    Diabetes Care; 2003 Aug; 26(8):2353-8. PubMed ID: 12882861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study.
    Molitch ME; Steffes M; Sun W; Rutledge B; Cleary P; de Boer IH; Zinman B; Lachin J;
    Diabetes Care; 2010 Jul; 33(7):1536-43. PubMed ID: 20413518
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.